Business / Finance

RSS

Retrophin reports net loss of $70.6 million for first quarter 2014

Retrophin, Inc. today reported its financial results for the quarter ended March 31, 2014.

14 May 2014

Medrobotics announces closing of $26M Series E Preferred Stock financing

Medrobotics Corp., a surgical products company with core competencies in medical robotics, announced today that it had closed its $26 Million Series E Preferred Stock financing. Existing Medrobotics shareholders and undisclosed new investors participated in the Series E raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches in Europe and the United States.

14 May 2014

Aradigm reports total revenue of $6.6 million for Q1 2014

Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2014.

14 May 2014

Eagle Pharmaceuticals total revenue increases by $2.5 million for Q2 2014

Eagle Pharmaceuticals, Inc. today announced its financial results for the three-month period ended March 31, 2014. This marks the first period for which Eagle is reporting financial results as a public company.

14 May 2014

Metabolon, GSK sign research collaboration agreement

Metabolon, Inc., a leading diagnostics and research services company offering metabolomics research platforms, has entered into a collaboration with GlaxoSmithKline to provide metabolomic profiling services and to collaborate on other research projects leveraging Metabolon's leading DiscoveryHD4 platform.

14 May 2014

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex, Inc. reports financial results for the three months ended March 31, 2014 and announces LCA-Vision stockholder approval of PhotoMedex's previously announced acquisition of all outstanding shares of LCA-Vision, a leading provider of laser vision correction services under the LasikPlus brand.

12 May 2014

GE Capital's Healthcare Financial Services provides $9 million term loan to Cerapedics

GE Capital's Healthcare Financial Services business has provided a $9 million term loan to Cerapedics, Inc., a privately-held medical device company based in Westminster, CO. The funds will be used to support Cerapedics' general business operations, including the advancement of its U.S. regulatory process.

12 May 2014

Quintiles agrees to acquire Encore Health Resources

As part of its continued efforts to strengthen and expand its service capabilities across the healthcare continuum, Quintiles today announced that it has signed an agreement to acquire Encore Health Resources.

12 May 2014

Akebia Therapeutics reports net loss of $9.7 million for Q1 2014

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with kidney disease, today announced financial results for the first quarter ended March 31, 2014.

12 May 2014

Foundation Medicine obtains CE mark for FoundationOne

Foundation Medicine, Inc. today announced that it has obtained a CE mark for FoundationOne®. The CE mark allows FoundationOne to be placed on the market in the European Economic Area.

12 May 2014

Inovio Pharmaceuticals reports total revenue of $2.4 million for first quarter 2014

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2014.

12 May 2014

GE Healthcare, Tesla Engineering announce collaboration to develop ultra high-field MRI systems

Today at the joint meeting of the International Society for Magnetic Resonance in Medicine and the European Society for Magnetic Resonance in Medicine and Biology, GE Healthcare and Tesla Engineering Ltd. announced that they will collaborate together to produce 7.0 tesla (7.0T) human whole-body magnetic resonance imaging (MRI) scanners, and build upon the ten year history of GE innovations in this advanced, technical field.

12 May 2014

Sirona second quarter fiscal 2014 revenue up 5.7%

Sirona, the dental technology leader, today announced its financial results for the quarter ended March 31, 2014.

9 May 2014

New Colombia Resources, Phoenix Tears Foundation to develop cannabis-based medicine for skin cancer

New Colombia Resources, Inc., a U.S. company with coal and other resource assets in Colombia, is pleased to announce an agreement of collaboration with the Phoenix Tears Foundation for the research and development of a cannabis based medicine to treat skin cancer in Colombia.

9 May 2014

Flatiron Health agrees to acquire Altos Solutions

Altos Solutions, creators of OncoEMR, the first web-based oncology-specific electronic medical record, today announced an agreement to be acquired by Flatiron Health.

9 May 2014

Antares Pharma reports total revenues of $5.2 million for first quarter 2014

Antares Pharma, Inc. today reported operating and financial results for the first quarter ended March 31, 2014.

9 May 2014

HMS Holdings revenue decreases 10.2% in Q1 2014

HMS Holdings Corp. today announced financial results for its first quarter ended March 31, 2014.

9 May 2014

Stratasys' total non-GAAP revenue grows by 54% in first quarter 2014

Stratasys Ltd. today announced first quarter financial results.

9 May 2014

Emergent BioSolutions reports total revenue of $53.9 million for Q1 2014

Emergent BioSolutions Inc. reported total revenue for Q1 2014 of $53.9 million as compared to $43.1 million in 2013. In addition, Q1 2014 net loss was $20.2 million, or $0.55 per share, as compared to a net loss of $8.1 million, or $0.22 per share, in 2013.

9 May 2014